Skip to main content

Advertisement

Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

Fig. 2

Kaplan–Meier curves indicating PCP-free survival in groups with medium-dose and high-dose groups. The medium-dose group is further stratified into a high-risk subgroup, with the presence of at least one risk factor (baseline lymphopenia and/or concomitant steroid pulse), and a non-high-risk subgroup, with no risk factors

Back to article page